 Allison Blackmer
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parenteral Nutrition | 10 | 2024 | 105 | 2.040 |
Why?
| | Education, Pharmacy | 5 | 2018 | 121 | 1.680 |
Why?
| | Fat Emulsions, Intravenous | 4 | 2024 | 29 | 1.480 |
Why?
| | Faculty, Pharmacy | 4 | 2017 | 20 | 1.330 |
Why?
| | Schools, Pharmacy | 4 | 2017 | 47 | 1.320 |
Why?
| | Career Mobility | 4 | 2017 | 72 | 1.280 |
Why?
| | Pharmacists | 5 | 2017 | 240 | 1.190 |
Why?
| | Career Choice | 4 | 2017 | 237 | 1.130 |
Why?
| | Neurodevelopmental Disorders | 3 | 2019 | 227 | 0.920 |
Why?
| | Cholestasis | 3 | 2024 | 219 | 0.830 |
Why?
| | Malnutrition | 5 | 2023 | 86 | 0.700 |
Why?
| | Nervous System Diseases | 2 | 2021 | 284 | 0.680 |
Why?
| | Drug Administration Schedule | 2 | 2021 | 783 | 0.680 |
Why?
| | Cannabidiol | 2 | 2022 | 136 | 0.650 |
Why?
| | Clostridium Infections | 1 | 2021 | 74 | 0.640 |
Why?
| | Motor Disorders | 1 | 2020 | 17 | 0.640 |
Why?
| | Muscle Spasticity | 1 | 2020 | 63 | 0.620 |
Why?
| | Lennox Gastaut Syndrome | 1 | 2019 | 19 | 0.570 |
Why?
| | Psychotropic Drugs | 1 | 2019 | 77 | 0.560 |
Why?
| | Cerebral Palsy | 1 | 2020 | 132 | 0.540 |
Why?
| | Parenteral Nutrition Solutions | 2 | 2015 | 3 | 0.540 |
Why?
| | Drug Monitoring | 1 | 2021 | 395 | 0.530 |
Why?
| | Self-Injurious Behavior | 1 | 2019 | 142 | 0.510 |
Why?
| | Professional Competence | 1 | 2017 | 98 | 0.510 |
Why?
| | Teaching | 1 | 2018 | 236 | 0.480 |
Why?
| | Chronic Disease | 2 | 2021 | 1813 | 0.470 |
Why?
| | Educational Measurement | 1 | 2018 | 326 | 0.460 |
Why?
| | Enteral Nutrition | 5 | 2023 | 216 | 0.450 |
Why?
| | Sleep Wake Disorders | 2 | 2016 | 302 | 0.440 |
Why?
| | Selenium | 1 | 2015 | 49 | 0.430 |
Why?
| | Trace Elements | 1 | 2015 | 52 | 0.430 |
Why?
| | Empyema, Pleural | 1 | 2014 | 13 | 0.410 |
Why?
| | Pleural Effusion | 1 | 2014 | 60 | 0.390 |
Why?
| | Catheter-Related Infections | 1 | 2013 | 94 | 0.370 |
Why?
| | Central Nervous System | 1 | 2014 | 281 | 0.360 |
Why?
| | Copper | 1 | 2012 | 113 | 0.360 |
Why?
| | Pediatrics | 4 | 2021 | 1115 | 0.350 |
Why?
| | Tissue Plasminogen Activator | 1 | 2014 | 244 | 0.350 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 292 | 0.330 |
Why?
| | Cross Infection | 1 | 2013 | 262 | 0.330 |
Why?
| | Laxatives | 1 | 2010 | 21 | 0.320 |
Why?
| | Dietary Fiber | 1 | 2010 | 59 | 0.320 |
Why?
| | Soybean Oil | 2 | 2024 | 15 | 0.320 |
Why?
| | Child | 12 | 2023 | 22657 | 0.300 |
Why?
| | Constipation | 1 | 2010 | 98 | 0.300 |
Why?
| | Polysaccharides | 1 | 2009 | 87 | 0.290 |
Why?
| | Humans | 35 | 2024 | 144957 | 0.280 |
Why?
| | Hospitalization | 2 | 2021 | 2434 | 0.280 |
Why?
| | Pneumonia | 1 | 2014 | 631 | 0.270 |
Why?
| | Thrombocytopenia | 1 | 2009 | 205 | 0.260 |
Why?
| | Students, Pharmacy | 2 | 2018 | 96 | 0.260 |
Why?
| | Infant | 7 | 2024 | 10039 | 0.240 |
Why?
| | Professional Role | 2 | 2017 | 158 | 0.240 |
Why?
| | Nutritional Support | 4 | 2022 | 39 | 0.240 |
Why?
| | Child, Preschool | 6 | 2021 | 11799 | 0.220 |
Why?
| | Anticoagulants | 1 | 2009 | 724 | 0.210 |
Why?
| | Nutrition Disorders | 1 | 2023 | 20 | 0.210 |
Why?
| | Food, Formulated | 1 | 2023 | 16 | 0.200 |
Why?
| | Bilirubin | 1 | 2024 | 97 | 0.200 |
Why?
| | Infant, Newborn | 5 | 2024 | 6434 | 0.200 |
Why?
| | Dietetics | 1 | 2023 | 24 | 0.190 |
Why?
| | Epilepsies, Myoclonic | 1 | 2022 | 59 | 0.180 |
Why?
| | Pharmaceutical Services | 1 | 2022 | 78 | 0.170 |
Why?
| | Nutrition Therapy | 1 | 2022 | 37 | 0.170 |
Why?
| | Public-Private Sector Partnerships | 1 | 2021 | 44 | 0.170 |
Why?
| | Prescription Drug Overuse | 1 | 2020 | 10 | 0.170 |
Why?
| | Vancomycin | 1 | 2021 | 93 | 0.160 |
Why?
| | Pharmacogenomic Testing | 1 | 2021 | 62 | 0.160 |
Why?
| | Medication Therapy Management | 1 | 2020 | 73 | 0.160 |
Why?
| | Symptom Assessment | 1 | 2020 | 137 | 0.150 |
Why?
| | United States | 9 | 2023 | 15988 | 0.150 |
Why?
| | Analgesics | 1 | 2020 | 231 | 0.140 |
Why?
| | Preceptorship | 1 | 2018 | 67 | 0.140 |
Why?
| | Health Personnel | 2 | 2023 | 748 | 0.140 |
Why?
| | Employee Performance Appraisal | 1 | 2017 | 7 | 0.140 |
Why?
| | Faculty | 1 | 2018 | 149 | 0.130 |
Why?
| | Feedback | 1 | 2017 | 181 | 0.130 |
Why?
| | Male | 8 | 2024 | 72406 | 0.120 |
Why?
| | Medicare | 1 | 2022 | 887 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2024 | 2032 | 0.120 |
Why?
| | Female | 8 | 2024 | 78376 | 0.110 |
Why?
| | Adolescent | 3 | 2021 | 22453 | 0.110 |
Why?
| | Electrolytes | 1 | 2015 | 55 | 0.110 |
Why?
| | Nutritionists | 1 | 2014 | 24 | 0.110 |
Why?
| | Academies and Institutes | 1 | 2014 | 60 | 0.100 |
Why?
| | Infant, Premature | 2 | 2024 | 611 | 0.100 |
Why?
| | Surveys and Questionnaires | 4 | 2023 | 6053 | 0.100 |
Why?
| | Societies, Medical | 1 | 2018 | 887 | 0.100 |
Why?
| | Vitamins | 1 | 2015 | 178 | 0.100 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 216 | 0.100 |
Why?
| | Adult | 5 | 2023 | 40506 | 0.100 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2015 | 149 | 0.100 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 5872 | 0.090 |
Why?
| | Parents | 1 | 2020 | 1403 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 710 | 0.090 |
Why?
| | Curriculum | 1 | 2018 | 1060 | 0.090 |
Why?
| | Infant, Premature, Diseases | 1 | 2012 | 111 | 0.080 |
Why?
| | Amino Acids | 1 | 2015 | 522 | 0.080 |
Why?
| | Nutritional Status | 2 | 2023 | 354 | 0.080 |
Why?
| | Anti-Bacterial Agents | 1 | 2021 | 1915 | 0.080 |
Why?
| | Clinical Competence | 1 | 2018 | 1244 | 0.080 |
Why?
| | Survival Analysis | 1 | 2013 | 1385 | 0.080 |
Why?
| | Socioeconomic Factors | 1 | 2014 | 1327 | 0.080 |
Why?
| | Glucose | 1 | 2015 | 1049 | 0.080 |
Why?
| | Young Adult | 2 | 2019 | 14126 | 0.070 |
Why?
| | Logistic Models | 1 | 2014 | 2119 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2014 | 11695 | 0.070 |
Why?
| | Child Welfare | 1 | 2010 | 231 | 0.070 |
Why?
| | Heparin | 1 | 2009 | 244 | 0.070 |
Why?
| | Quality of Life | 1 | 2020 | 3192 | 0.070 |
Why?
| | Critical Illness | 1 | 2013 | 892 | 0.060 |
Why?
| | Incidence | 1 | 2013 | 2883 | 0.060 |
Why?
| | Retrospective Studies | 2 | 2015 | 17101 | 0.060 |
Why?
| | Practice Guidelines as Topic | 2 | 2014 | 1563 | 0.060 |
Why?
| | Risk Assessment | 1 | 2015 | 3676 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 1054 | 0.050 |
Why?
| | Societies | 1 | 2023 | 40 | 0.050 |
Why?
| | Liver | 1 | 2012 | 1888 | 0.050 |
Why?
| | Age Factors | 1 | 2010 | 3335 | 0.050 |
Why?
| | Nutrition Assessment | 1 | 2023 | 92 | 0.050 |
Why?
| | Fenfluramine | 1 | 2022 | 17 | 0.050 |
Why?
| | Algorithms | 1 | 2010 | 1839 | 0.050 |
Why?
| | Drug Storage | 1 | 2022 | 53 | 0.050 |
Why?
| | Drug Stability | 1 | 2022 | 164 | 0.040 |
Why?
| | Prospective Studies | 1 | 2014 | 7997 | 0.040 |
Why?
| | United States Food and Drug Administration | 1 | 2022 | 205 | 0.040 |
Why?
| | Epileptic Syndromes | 1 | 2022 | 96 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2013 | 8279 | 0.040 |
Why?
| | Behavioral Symptoms | 1 | 2020 | 43 | 0.040 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 170 | 0.040 |
Why?
| | Spasms, Infantile | 1 | 2022 | 136 | 0.040 |
Why?
| | Anticonvulsants | 1 | 2022 | 242 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2021 | 173 | 0.040 |
Why?
| | Temperature | 1 | 2022 | 679 | 0.040 |
Why?
| | Aged | 2 | 2022 | 25947 | 0.040 |
Why?
| | Seizures | 1 | 2022 | 477 | 0.030 |
Why?
| | Research | 1 | 2021 | 431 | 0.030 |
Why?
| | Data Collection | 1 | 2020 | 635 | 0.030 |
Why?
| | Work | 1 | 2017 | 23 | 0.030 |
Why?
| | Time Management | 1 | 2017 | 21 | 0.030 |
Why?
| | Health Care Costs | 1 | 2021 | 427 | 0.030 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2020 | 194 | 0.030 |
Why?
| | Occupational Stress | 1 | 2017 | 46 | 0.030 |
Why?
| | Precision Medicine | 1 | 2021 | 458 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 732 | 0.030 |
Why?
| | Intestinal Diseases | 1 | 2016 | 43 | 0.030 |
Why?
| | Patient Care Team | 1 | 2022 | 689 | 0.030 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2016 | 106 | 0.030 |
Why?
| | Diet | 1 | 2023 | 1275 | 0.030 |
Why?
| | History, 21st Century | 1 | 2016 | 219 | 0.030 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 238 | 0.030 |
Why?
| | Length of Stay | 1 | 2021 | 1337 | 0.030 |
Why?
| | History, 20th Century | 1 | 2016 | 325 | 0.030 |
Why?
| | Pain | 1 | 2020 | 782 | 0.030 |
Why?
| | Patient Discharge | 1 | 2021 | 983 | 0.030 |
Why?
| | Cooperative Behavior | 1 | 2017 | 465 | 0.030 |
Why?
| | Interpersonal Relations | 1 | 2017 | 400 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2925 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1416 | 0.020 |
Why?
| | Quality Improvement | 1 | 2020 | 1291 | 0.020 |
Why?
| | Middle Aged | 1 | 2013 | 35928 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4564 | 0.020 |
Why?
|
|
Blackmer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|